Amsterdam, September 26, 2022 – Demand for donor livers for transplant patients outstrips supply with over 15% of waitlist patients dying after a year. A new international study offers support for increasing the use of living donor liver transplantation (LDLT)…
From the very beginning, EASL’s mission has been to be the “Home of Hepatology”. Providing education to everyone interested in hepatology and engaging with all stakeholders in the liver field wherever they are based. Through its 66 years of existence,…
Although DAA medications have demonstrated excellent safety and efficacy in non-pregnant individuals, they are not currently approved for HCV treatment in pregnant women due to a lack of safety data. Clinical trials assessing the safety of DAAs in pregnancy and…
Follow us @easl.news on Instagram Like the contest post Comment under the post how you are joining the MOVEment against NAFLD Post a Story showing how you fight NAFLD by tagging us @easl.news + using #nafldsummit Entries will on 14…
The 2-day meeting in Chicago on 8-9 July 2022 convened 129 consensus survey participants in person or online. The participants originated from 32 countries, representing multiple societies including AASLD, EASL, APASL, ALEH, AGA and UEG, patients and patient advocacy organizations,…
EASL is opening the call for hosting three clinical and one basic EASL School to be held in 2024. If you are an EASL Member, submit your proposal before 30 September 2022.
Prof. Vinay Sundaram, Associate Professor of Medicine and Director of Hepatology Outcomes Research at Cedars-Sinai Medical Center, passed away on July 14, 2022. Prof. Sundaram was one of the leading researchers in the field of acute-on-chronic liver failure and was…
EASL has launched several highly influential Clinical Practice Guidelines (CPGs). The objective of these CPGs is to provide simple, clear, and evidence-based guidelines that can be used for patient management and reimbursement policies all over Europe. EASL CPGs have become…
